X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Aurobindo Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs AUROBINDO PHARMA - Comparison Results

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE AUROBINDO PHARMA SUVEN LIFE/
AUROBINDO PHARMA
 
P/E (TTM) x 16.2 18.0 90.3% View Chart
P/BV x 3.0 5.8 51.6% View Chart
Dividend Yield % 1.2 0.4 350.4%  

Financials

 SUVEN LIFE   AUROBINDO PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
AUROBINDO PHARMA
Mar-16
SUVEN LIFE/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs3391,541 22.0%   
Low Rs144582 24.8%   
Sales per share (Unadj.) Rs39.2237.5 16.5%  
Earnings per share (Unadj.) Rs7.533.9 22.0%  
Cash flow per share (Unadj.) Rs8.840.6 21.6%  
Dividends per share (Unadj.) Rs2.002.50 80.0%  
Dividend yield (eoy) %0.80.2 351.6%  
Book value per share (Unadj.) Rs49.0120.6 40.6%  
Shares outstanding (eoy) m127.28585.17 21.8%   
Bonus/Rights/Conversions -PREF-  
Price / Sales ratio x6.24.5 137.7%   
Avg P/E ratio x32.431.3 103.3%  
P/CF ratio (eoy) x27.526.2 105.2%  
Price / Book Value ratio x4.98.8 56.0%  
Dividend payout %26.87.4 363.1%   
Avg Mkt Cap Rs m30,732621,041 4.9%   
No. of employees `0001.013.3 7.2%   
Total wages/salary Rs m41615,508 2.7%   
Avg. sales/employee Rs Th5,236.110,457.6 50.1%   
Avg. wages/employee Rs Th436.51,167.1 37.4%   
Avg. net profit/employee Rs Th995.51,491.6 66.7%   
INCOME DATA
Net Sales Rs m4,995138,961 3.6%  
Other income Rs m1941,663 11.6%   
Total revenues Rs m5,189140,624 3.7%   
Gross profit Rs m1,23332,056 3.8%  
Depreciation Rs m1673,926 4.3%   
Interest Rs m542,568 2.1%   
Profit before tax Rs m1,20527,225 4.4%   
Minority Interest Rs m039 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2557,444 3.4%   
Profit after tax Rs m95019,820 4.8%  
Gross profit margin %24.723.1 107.0%  
Effective tax rate %21.227.3 77.4%   
Net profit margin %19.014.3 133.3%  
BALANCE SHEET DATA
Current assets Rs m4,986100,015 5.0%   
Current liabilities Rs m1,04274,759 1.4%   
Net working cap to sales %79.018.2 434.4%  
Current ratio x4.81.3 357.6%  
Inventory Days Days61107 56.8%  
Debtors Days Days39110 35.7%  
Net fixed assets Rs m3,12652,350 6.0%   
Share capital Rs m127585 21.8%   
"Free" reserves Rs m3,71767,707 5.5%   
Net worth Rs m6,23670,567 8.8%   
Long term debt Rs m4328,472 5.1%   
Total assets Rs m8,079156,994 5.1%  
Interest coverage x23.211.6 200.2%   
Debt to equity ratio x0.10.1 57.7%  
Sales to assets ratio x0.60.9 69.9%   
Return on assets %12.414.3 87.1%  
Return on equity %15.228.1 54.2%  
Return on capital %18.937.7 50.0%  
Exports to sales %87.551.0 171.4%   
Imports to sales %12.218.8 64.9%   
Exports (fob) Rs m4,37170,927 6.2%   
Imports (cif) Rs m61126,193 2.3%   
Fx inflow Rs m4,66671,015 6.6%   
Fx outflow Rs m94228,799 3.3%   
Net fx Rs m3,72442,216 8.8%   
CASH FLOW
From Operations Rs m92217,596 5.2%  
From Investments Rs m-619-13,801 4.5%  
From Financial Activity Rs m-698-198 352.2%  
Net Cashflow Rs m-3963,597 -11.0%  

Share Holding

Indian Promoters % 63.4 54.1 117.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 8.0 -  
FIIs % 0.0 27.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.2 357.8%  
Shareholders   37,287 69,601 53.6%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  CADILA HEALTHCARE  GSK PHARMA  PANACEA BIOTECH  

Compare SUVEN LIFE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS